Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment
出版年份 2016 全文链接
标题
Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment
作者
关键词
-
出版物
GENE THERAPY
Volume 24, Issue 2, Pages 92-103
出版商
Springer Nature
发表日期
2016-12-01
DOI
10.1038/gt.2016.80
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients
- (2016) Angelica Loskog et al. BRITISH JOURNAL OF CANCER
- VEGF suppresses T-lymphocyte infiltration in the tumor microenvironment through inhibition of NF-κB-induced endothelial activation
- (2015) Hua Huang et al. FASEB JOURNAL
- PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors
- (2015) Kevin C. Soares et al. JOURNAL OF IMMUNOTHERAPY
- Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms
- (2015) Tamás Rőszer MEDIATORS OF INFLAMMATION
- Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma
- (2015) R. Winograd et al. Cancer Immunology Research
- CD40L gene therapy tilts the myeloid cell profile and promotes infiltration of activated T lymphocytes
- (2014) L Liljenfeldt et al. CANCER GENE THERAPY
- Adenovirus Vector-Induced Innate Inflammatory Mediators, MAPK Signaling, As Well As Adaptive Immune Responses Are Dependent upon Both TLR2 and TLR9 In Vivo
- (2014) D. M. Appledorn et al. JOURNAL OF IMMUNOLOGY
- Multifunctional CD40L: pro- and anti-neoplastic activity
- (2014) Aleksandra Korniluk et al. TUMOR BIOLOGY
- Treatment Efficacy and Immune Stimulation by AdCD40L Gene Therapy of Spontaneous Canine Malignant Melanoma
- (2013) Sara Westberg et al. JOURNAL OF IMMUNOTHERAPY
- Elevated serum soluble CD40 ligand in cancer patients may play an immunosuppressive role
- (2012) J. Huang et al. BLOOD
- Oncolytic Immunotherapy of Advanced Solid Tumors with a CD40L-Expressing Replicating Adenovirus: Assessment of Safety and Immunologic Responses in Patients
- (2012) S. Pesonen et al. CANCER RESEARCH
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune modulation with weekly dosing of an agonist CD40 antibody in a phase I study of patients with advanced solid tumors
- (2011) Jens Rüter et al. CANCER BIOLOGY & THERAPY
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- CD40/CD40L interaction induces E-selectin dependent leukocyte adhesion to human endothelial cells and inhibits endothelial cell migration
- (2010) Daniel Urban et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- AdCD40L Immunogene Therapy for Bladder Carcinoma--The First Phase I/IIa Trial
- (2010) P.-U. Malmstrom et al. CLINICAL CANCER RESEARCH
- Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
- (2010) Richard E. Royal et al. JOURNAL OF IMMUNOTHERAPY
- Minimal RB-responsive E1A Promoter Modification to Attain Potency, Selectivity, and Transgene-arming Capacity in Oncolytic Adenoviruses
- (2010) Juan J Rojas et al. MOLECULAR THERAPY
- Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors
- (2009) Sergey S Seregin et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- CD40 Ligand-Induced Carcinoma Cell Death: A Balance between Activation of TNFR-Associated Factor (TRAF) 3-Dependent Death Signals and Suppression of TRAF6-Dependent Survival Signals
- (2009) T. Elmetwali et al. JOURNAL OF IMMUNOLOGY
- Efficient Adenovector CD40 Ligand Immunotherapy of Canine Malignant Melanoma
- (2009) Henrik von Euler et al. JOURNAL OF IMMUNOTHERAPY
- The Janus faces of CD40 in cancer
- (2009) Angelica S.I. Loskog et al. SEMINARS IN IMMUNOLOGY
- Multiple innate signaling pathways cooperate with CD40 to induce potent, CD70-dependent cellular immunity
- (2009) Jennifer A. McWilliams et al. VACCINE
- Increased therapeutic efficacy of the prostate-specific oncolytic adenovirus Ad[I/PPT-E1A] by reduction of the insulator size and introduction of the full-length E3 region
- (2008) A Danielsson et al. CANCER GENE THERAPY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started